GlassScriptPhysician profile
Jeryl Pittman
NPI 1891990479
$5,703.99
in general payments reported to CMS, 2019-2025
40 companies · $715 in 2025
The $715 reported for 2025 was more than what 81% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,317 · 2022: $1,327 · 2023: $1,450 · 2024: $895 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,060.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $753.62 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Vanda Pharmaceuticals INC. | $554.61 | 2022-2025 | Fanapt, Hetlioz |
| Abbvie INC. | $523.22 | 2021-2025 | |
| Glaxosmithkline, LLC. | $454.08 | 2021-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $399.60 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $377.00 | 2021-2025 | Repatha, Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $264.25 | 2021-2025 | |
| Antares Pharma, INC. | $183.44 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $161.33 | 2021-2025 | |
| Almatica Pharma LLC | $158.84 | 2023-2024 | Loreev Xr |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $148.80 | 2021-2025 | Xifaxan, Relistor |
| Bayer Healthcare Pharmaceuticals INC. | $141.38 | 2022-2025 | |
| Halozyme INC | $116.40 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $114.00 | 2021-2025 | Trintellix |
| Sanofi-Aventis U.S. LLC | $106.39 | 2021-2023 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeryl Pittman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.